Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
パッケージサイズ | 在庫状況 | 単価(税別) | |
---|---|---|---|
2 mg | お問い合わせ | ¥ 38,500 | |
5 mg | お問い合わせ | ¥ 55,000 | |
10 mg | お問い合わせ | お問い合わせ | |
25 mg | お問い合わせ | お問い合わせ | |
50 mg | お問い合わせ | お問い合わせ | |
1 mL * 10 mM (in DMSO) | お問い合わせ | ¥ 62,000 |
説明 | Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren's syndrome. |
分子量 | 489.55 |
分子式 | C20H38Cl2N2O3S2 |
CAS No. | 153504-70-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cevimeline hydrochloride hemihydrate 153504-70-2 Neuroscience AChR SNI 2011 Cevimeline hydrochloride Hemihydrate secretion SNI-2011 dry Quinuclidine Muscarinic acetylcholine receptor SNI2011 muscarinic xerostomia mAChR long-acting Cevimeline Hydrochloride parasympathomimetic AF102B hydrochloride hemihydrate Inhibitor sialogogue inhibit salivation mouth inhibitor